Mercy BioAnalytics, Inc.
Mercy BioAnalytics is a cancer diagnostics startup developing blood tests that detect tumor-derived extracellular vesicles, with 64 employees and $127M in funding. The company's Series B round closed in September 2025, with backers including the American Cancer Society and Bruker.
The growth story
Mercy BioAnalytics, Inc. grew from 19 to 64 employees between 2021 and 2026, raising $127M along the way, most recently a Series B in September 2025.
About
Mercy BioAnalytics makes liquid biopsy tests that analyze extracellular vesicles in blood to identify cancer at early stages. Their technology targets the oncology diagnostics market where early detection significantly improves outcomes.
The company has raised $127M, most recently in a 2025 Series B. Its 64-person team includes 18 researchers, with heavy recruitment from diagnostics firms like Quanterix and Natera.
Founders and leadership
Research is the largest department with 18 staff. Leadership includes alumni from major diagnostics and biotech firms, though specific executives aren't named in the data.
The Mercy BioAnalytics, Inc. org chart
Dawn Mattoon (Chief Executive Officer) leads 30 mapped leaders with 6 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 21 (+11% YoY), Business Development 10 (+25% YoY), Operations 6 (+50% YoY), Engineering 4 (+100% YoY), Healthcare Services 3 (+200% YoY).
Talent flow
The team draws heavily from cancer diagnostics peers, with 8 hires from Quanterix and multiple from Natera and Labcorp. Alumni have founded at least two biotech startups, including Amplifyer Bio.
Most common previous employers of Mercy BioAnalytics, Inc. staff: Quanterix (8), T2 Biosystems (4), Natera (3), Labcorp (3), Cell Signaling Technology (CST) (3), Sherlock Biosciences (3). Former Mercy BioAnalytics, Inc. employees most often moved to University of Michigan (2), Parker Institute for Cancer Immunotherapy (1), Flagship Labs 103 (1), Bayer (1), Monster Energy (1), Amplifyer Bio (1).
Alumni worth knowing
Web traffic
Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of
Most common skills at Mercy BioAnalytics, Inc.: Biotechnology (25), Life Sciences (21), Molecular Biology (21), Research Skills (20), Data Analysis (19), Leadership (19), Microsoft Office (16), Assay Development (15).
Where the team actually sits
Mercy BioAnalytics, Inc. people are concentrated in Massachusetts, United States (23), United States (13), Greater Boston (8), Florida, United States (2).
Search footprint
Mercy BioAnalytics, Inc. attracts about 73 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 6 ranking keywords and lost 4 in the last period.
What employees say
- Compensation
- 5.00 / 5
- Career opportunities
- 5.00 / 5
- Senior management
- 5.00 / 5
- Work-life balance
- 4.40 / 5
Frequently asked
Mercy BioAnalytics, Inc. has 64 employees as of September 2026.
Mercy BioAnalytics, Inc. has raised $127M in total, most recently a Series B round in September 2025.
Dawn Mattoon (Chief Executive Officer) sits at the top of Mercy BioAnalytics, Inc.'s reporting structure, with 6 direct reports.
The most common previous employers of current Mercy BioAnalytics, Inc. staff are Quanterix (8 people), T2 Biosystems (4 people), Natera (3 people).
Former Mercy BioAnalytics, Inc. employees most often move to University of Michigan (2), Parker Institute for Cancer Immunotherapy (1), Flagship Labs 103 (1).
Mercy BioAnalytics, Inc. attracts about 73 organic search visits a month, worth roughly $0K a month in equivalent ad spend.
The most common skills among Mercy BioAnalytics, Inc. staff are Biotechnology, Life Sciences, Molecular Biology, Research Skills, Data Analysis.
Mercy BioAnalytics, Inc. staff are concentrated in Massachusetts, United States (23), United States (13), Greater Boston (8).
Mercy BioAnalytics, Inc. has about 21 people in Research, up 11% over the past year, as of September 2026.
Mercy BioAnalytics, Inc. has about 10 people in Business Development, up 25% over the past year, as of September 2026.
Computed from 55 current and 28 former Mercy BioAnalytics, Inc. profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.